InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,160.38
(
0.64%
)
US TECH 100
17,522.40
(
0.59%
)
Dow Jones
38,774.90
(
0.26%
)
Brent Oil
83.02
(
-0.13%
)
Bitcoin
63,282.68
(
-1.12%
)
Post# of 39183
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

GOALIE1

Send PM Follow Ignore
Followers 26
Posts 5707
Boards Moderated 0
Alias Born 10/01/2011

GOALIE1

Re: bobbie60 post# 38125

Monday, 02/25/2019 11:48:30 PM

Monday, February 25, 2019 11:48:30 PM

Post# of 39183
One indication of non-growth is the lack of additional reviews for Emesyl and Emesyl Plus; stuck at 112 and 3 reviews respectively. I'm also not optimistic about the Form 10-K due on or about 2/28/2019.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!